ARTICLE | Clinical News
HLA-B7: Protocol for a Phase I/II trial approved
December 6, 1993 8:00 AM UTC
Vical Inc. (VICL) Product: Vector and cytofectin liposome encoding HLA-B7 major histocompatibility complex protein Indication: Advanced colorectal carcinoma Status: Protocol for a Phase I/II trial de...